HTLV-1 Envelope Recombinant, HTLV-1 Envelope, 500ug

CAT No.BT-HIV-107

HTLV-1 Envelope Recombinant, HTLV-1 Envelope, 500ug

---

Applications
HTLV-1 Envelope can be used as an antigen in ELISA and Western Blots. Excellent reagent for correct detection of HTLV infections, with minimal specificity problems.

Description
The E.Coli derived recombinant protein contains the C- terminus of gp46 and most of p21E of HTLV-1. This non-fusion, E. coli-derived protein, starts from HIV-1 env. Amino acid 165, and is ending in amino acid 440, Mw 27 kDa.

Formulation
10mM Na-PO4 pH 6.0, 0.1% SDS and 1mM DTT.

HTLV-1 Envelope was purified by proprietary chromatographic technique.

Purity
HTLV-1 Envelope protein is >95% pure as determined by 10% PAGE (coomassie staining) and RP-HPLC.

Solubility
It is recommended to reconstitute the lyophilized HTLV-1 Envelope in sterile 18M¦¸-cm H2O not less than 100ug/ml, which can then be further diluted to other aqueous solutions.

Specificity
Immunoreactive with all sera of HTLV-I and HTLV-II infected individuals with antibody response to HTLV envelope.

Stability
Lyophilized HTLV-1 Envelope although stable at room temperature for 3 weeks, should be stored desiccated below - 18¡ãC. Upon reconstitution HTLV-1 Envelope should be stored at 4¡ãC between 2-7 days and for future use below -18¡ãC. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.

Storage
HTLV-1 Envelope protein is shipped at ambient temperature. Upon arrival, Store at -20¡ãC.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.